<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Vasopressors_and_inotropes</id>
	<title>Vasopressors and inotropes - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Vasopressors_and_inotropes"/>
	<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Vasopressors_and_inotropes&amp;action=history"/>
	<updated>2026-04-28T19:42:58Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://idwiki.org/index.php?title=Vasopressors_and_inotropes&amp;diff=4520&amp;oldid=prev</id>
		<title>Maintenance script: Imported from text file</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Vasopressors_and_inotropes&amp;diff=4520&amp;oldid=prev"/>
		<updated>2020-07-04T01:18:01Z</updated>

		<summary type="html">&lt;p&gt;Imported from text file&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Receptors ==&lt;br /&gt;
&lt;br /&gt;
* Alpha-adrenergic receptors:&lt;br /&gt;
** Alpha-1 agonists cause vasoconstriction&lt;br /&gt;
** Alpha-2 agonists causes vasodilatation especially of coronary arteries&lt;br /&gt;
* Beta-adrenergic receptors:&lt;br /&gt;
** Beta-1 agonists increases HR and cardiac contractility --&amp;amp;gt; increased CO&lt;br /&gt;
** Beta-2 agonists dilate small coronary A&amp;#039;s, visceral organ A&amp;#039;s, skeletal muscle A&amp;#039;s and increase bronchodilation&lt;br /&gt;
* Dopaminergic receptors:&lt;br /&gt;
** 7 types of dopamine receptors&lt;br /&gt;
** D4 agonists increase cardiac contractility&lt;br /&gt;
** D1 and D2 agonists increase renal diuresis and naturesis&lt;br /&gt;
* Vasopressin receptors:&lt;br /&gt;
** V1 agonists cause vasoconstriction mostly in peripheral arterioles and increased sensitivity to catecholamines&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
! Pressor&lt;br /&gt;
! Alpha&lt;br /&gt;
! Beta-1&lt;br /&gt;
! Beta-2&lt;br /&gt;
! Notes&lt;br /&gt;
|-&lt;br /&gt;
| Dobutamine&lt;br /&gt;
| –&lt;br /&gt;
| ++&lt;br /&gt;
| +&lt;br /&gt;
| More of an inotrope, really.&lt;br /&gt;
|-&lt;br /&gt;
| Dopamine, moderate&lt;br /&gt;
| –&lt;br /&gt;
| +++&lt;br /&gt;
| +++&lt;br /&gt;
| Precursor to norepi/epi. Higher risk of tachyarrhythmias than norepi.&lt;br /&gt;
|-&lt;br /&gt;
| Dopamine, high&lt;br /&gt;
| ++&lt;br /&gt;
| +++&lt;br /&gt;
| +++&lt;br /&gt;
| More alpha with high doses.&lt;br /&gt;
|-&lt;br /&gt;
| Epinephrine&lt;br /&gt;
| +++&lt;br /&gt;
| ++++&lt;br /&gt;
| +++&lt;br /&gt;
| Increases lactate.&lt;br /&gt;
|-&lt;br /&gt;
| Norepinephrine&lt;br /&gt;
| +++&lt;br /&gt;
| +&lt;br /&gt;
| –&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
| Phenylephrine&lt;br /&gt;
| +++&lt;br /&gt;
| –&lt;br /&gt;
| –&lt;br /&gt;
| Beware reflex bradycardia.&lt;br /&gt;
|-&lt;br /&gt;
| Vasopressin&lt;br /&gt;
| –&lt;br /&gt;
| –&lt;br /&gt;
| –&lt;br /&gt;
| Acts on V1 receptors. Increase SVR and can cause ischemia.&lt;br /&gt;
|-&lt;br /&gt;
| Milrinone&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
| Phosphodiesterase III inhibitor. Avoid in renal failure. Long half-life.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Treatment Algorithms ==&lt;br /&gt;
&lt;br /&gt;
* Distributive shock: norepinephrine, then add vasopressin or epinephrine, then add dopamine or dobutamine&lt;br /&gt;
* Cardiogenic shock&lt;br /&gt;
** If left heart failure and BP can tolerate: Dobutamine&lt;br /&gt;
** If right heart failure and BP can tolerate: Milrinone&lt;br /&gt;
* Opioid-induced hypotension: phenylephrine&lt;br /&gt;
&lt;br /&gt;
[[Category:Critical care]]&lt;br /&gt;
[[Category:Medications]]&lt;/div&gt;</summary>
		<author><name>Maintenance script</name></author>
	</entry>
</feed>